
Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants
Plitidepsin was 27.5-fold more potent against SARS-CoV-2 than remdesivir, a drug that received FDA emergency use authorization in 2020 for the treatment of COVID-19, according to new research.
Jan 26, 2021








